Analogic’s new multipurpose SyneRad OMNI DR digital radiography system is debuting this week at RSNA 2004. The system received FDA 510(k) clearance just last week.
Analogic's new multipurpose SyneRad OMNI DR digital radiography system is debuting this week at RSNA 2004. The system received FDA 510(k) clearance just last week.
SyneRad features the company's new GR17 amorphous selenium flat-panel detector, which was developed by Analogic's Canadian subsidiary Anrad. Analogic designs and manufactures advanced health and security systems.
The new system is being sold by Anexa, another Analogic subsidiary that sells digital imaging products directly to end-users in select U.S. markets.
"We've designed the SyneRad OMNI to meet the clinical demands of our emergency medicine and orthopedic office customers," said John Ross, vice president of marketing for Anexa.
The SyneRad OMNI provides multiframe acquisition in 17 x 17-inch fields, providing expanded clinical utility in joint stability and motion studies.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.